← back to search

Graciela S. Alarcón

University of Alabama at Birmingham · US
🔎 Find collaborators in Rheumatology · Pathology and Forensic Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research interests include Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Systemic Sclerosis and Related Diseases, and Atherosclerosis and Cardiovascular Diseases.
h-index
85
citations
35,913
works
639
NIH funding
primary concept
email

Recent publications

Item-specific factors associated with damage accrual in systemic lupus erythematosus: insights from a multiethnic, multinational Latin American cohort
Lupus Science & Medicine 2025cited by 4position: middledoi
MACHINE LEARNING CAN IDENTIFY AN ANTINUCLEAR ANTIBODY PATTERN THAT MAY RULE OUT SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES
The Journal of Rheumatology 2025cited by 3position: middledoi
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring
Arthritis & Rheumatology 2025cited by 2position: middledoi
Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica
Rheumatology Advances in Practice 2024cited by 15position: lastdoi
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort
Lupus 2024cited by 8position: middledoi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus
Lupus Science & Medicine 2024cited by 3position: middledoi
Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients
Lupus 2024cited by 3position: middledoi
A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2
Lupus 2024cited by 2position: lastdoi
POS0280 EFFECTIVENESS OF METHOTREXATE AND LEFLUNOMIDE AS CORTICOID-SPARING DRUGS IN PATIENTS WITH POLYMYALGIA RHEUMATICA
Annals of the Rheumatic Diseases 2024cited by 1position: lastdoi
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
Annals of the Rheumatic Diseases 2023cited by 78position: middledoi
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the <scp>SLICC</scp> Inception Cohort
Arthritis & Rheumatology 2023cited by 39position: middledoi
Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus
Frontiers in Medicine 2023cited by 12position: lastdoi
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
Lupus Science & Medicine 2023cited by 10position: lastdoi
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort
Lupus 2023cited by 10position: middledoi
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Annals of the Rheumatic Diseases 2022cited by 91position: middledoi
Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades
Annals of the Rheumatic Diseases 2022cited by 63position: middledoi
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Annals of the Rheumatic Diseases 2022cited by 51position: lastdoi
LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
Lupus Science & Medicine 2022cited by 24position: middledoi
Association Between Race/Ethnicity and <scp>COVID</scp>‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the <scp>COVID</scp>‐19 Global Rheumatology Alliance
Arthritis Care & Research 2022cited by 22position: middledoi
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Annals of the Rheumatic Diseases 2022cited by 21position: middledoi
Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter <scp>US</scp> Cohort of Patients With Lupus
Arthritis Care & Research 2022cited by 16position: lastdoi
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
Lupus Science & Medicine 2022cited by 16position: middledoi
The SLICC-FI Predicts Damage Accrual in SLE Patients. Data From the Almenara Lupus Cohort
Lupus 2022cited by 15position: middledoi
2021 DORIS definition of remission in SLE: final recommendations from an international task force
Lupus Science & Medicine 2021cited by 329position: middledoi
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort
Lara D. Veeken 2021cited by 105position: middledoi
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Annals of the Rheumatic Diseases 2021cited by 96position: middledoi
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies
Lupus Science & Medicine 2021cited by 88position: lastdoi
Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review
Lupus Science & Medicine 2021cited by 57position: middledoi
Evaluating the Construct of Damage in Systemic Lupus Erythematosus
Arthritis Care & Research 2021cited by 24position: middledoi
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort
Arthritis & Rheumatology 2021cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Manuel F. Ugarte‐Gil · Universidad Científica del Sur32 papers (2014–2023)Guillermo Pons‐Estel · University of Alabama at Birmingham18 papers (2012–2023)Bernardo A. Pons‐Estel · Wake Forest University17 papers (2014–2023) · 12 papers (2016–2023)Daniel Wojdyla · University of Kentucky11 papers (2014–2020) · 10 papers (2015–2023) · 9 papers (2014–2023) · 9 papers (2014–2023)Gerald McGwin · University of Alabama at Birmingham9 papers (2013–2022) · 8 papers (2014–2022) · 8 papers (2014–2023) · 8 papers (2015–2023) · 8 papers (2014–2023) · 7 papers (2013–2022) · 7 papers (2017–2023)John D. Reveille · Dartmouth College7 papers (2013–2022) · 7 papers (2014–2023) · 7 papers (2015–2023) · 7 papers (2018–2023) · 6 papers (2014–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Rheumatology · Pathology and Forensic Medicine →